News & Events

We are pleased to announce that our Histopathology & Cytology team in UAE has achieved a major accomplishment. Indeed, Zahrawi Group has received the “EMEAI Best Regional Performer Pathology 2021” award handed by Agilent during the CY 2021 Result & Awards Celebration on the 17th January 2022. United Arab Emirates is a mature market where […]

Read more

We are proud to announce that our Structural Heart & Neuromodulation unit in KSA has successfully implanted a Watchman FLX device from our partner Boston Scientific at King Fahad University Hospital in Khobar, where Dr. Mansouri and his team operated a 61-year-old patient with repeated TIAs and who was suffering from Atrial Fibrillation. The new […]

Read more

Since March 2021, Zahrawi Group Neuromodulation Unit in KSA successfully trained many pain management HCPs in the Kingdom to use the Radiofrequency – Boston Scientific – as a safe and proven mean of interrupting pain signals, such as those coming from irritated facet joints in the spine, genicular nerves in the knee, and femoral and obturator […]

Read more

Mr. Abdulrahman Ramadan Zahrawi Group Vice President & Acting CEO is pleased to announce Zahrawi Group Vision & Mission statements as follow. Vision: To be the leading, most trusted partner for medical devices and life sciences in the GCC region. Mission: With an unyielding mission to improving people’s lives every day, Zahrawi is committed to […]

Read more

Zahrawi Group is proud and honoured to announce that our KSA office has been awarded the ISO 9001: 2015 for quality management system as well as the ISO 13485: 2016 for Medical devices — Quality management systems, two internationally recognised standards that ensures we meet the needs of our customers through an effective quality management […]

Read more